enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Celecoxib - Wikipedia

   en.wikipedia.org/wiki/Celecoxib

   Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). [7] It is used to treat the pain and inflammation in osteoarthritis , acute pain in adults, rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis , painful menstruation , and juvenile rheumatoid ...

3. Cyclooxygenase-2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/Cyclooxygenase-2_inhibitor

   Celebrex (and other brand names for celecoxib) was introduced in 1999 and rapidly became the most frequently prescribed new drug in the United States. By October 2000, its US sales exceeded 100 million prescriptions per year for $3 billion, and was still rising. Sales of Celebrex alone reached $3.1 billion in 2001.

4. Discovery and development of cyclooxygenase 2 inhibitors

   en.wikipedia.org/wiki/Discovery_and_development...

   [5] [6] It took less than eight years to develop and market the first COX-2 inhibitor, with Celebrex launched in December 1998 and Vioxx launched in May 1999. [ 7 ] [ 8 ] Celecoxib and other COX-2 selective inhibitors, valdecoxib , parecoxib , and mavacoxib , were discovered by a team at the Searle division of Monsanto led by John Talley .

5. 3 Reasons Pfizer, Inc. Can Overcome Celebrex Patent Loss - AOL

   www.aol.com/news/2014-03-13-3-reasons-pfizer-inc...

   As Celebrex is Pfizer's fourth best-selling drug, raking in $2.9 billion in revenue in 2013 and showing stellar growth year over year of 9%, it's understandable if this court decision rattles ...

6. Pfizer Gets 18 More Months of Celebrex Patent Protection - AOL

   www.aol.com/news/2013-03-05-pfizer-gets-18-more...

   There's reason to celebrate for Celebrex. Pfizer announced today that the U.S. Patent and Trademark Office has added 18 months onto the pharmaceutical company's previous patent for the painkiller ...

7. Investors Don't Celebrate Celebrex Decision Favoring Cheap ...

   www.aol.com/news/2014-03-16-investors-dont...

   Biotech investors are no stranger to a trading halt that brings game-changing news to a stock, but you don't see it very often when it comes to big pharmaceutical companies, especially ones with ...

8. Rofecoxib - Wikipedia

   en.wikipedia.org/wiki/Rofecoxib

   The therapeutic recommended dosages were 12.5, 25, and 50 mg with an approximate bioavailability of 93%. [12] [13] [14] Rofecoxib crossed the placenta and blood–brain barrier, [12] [13] [15] and took 1–3 hours to reach peak plasma concentration with an effective half-life (based on steady-state levels) around 17 hours.

9. FDA approves first new type of pain medication in 25 years - AOL

   www.aol.com/news/fda-approves-first-type-pain...

   Suzetrigine is the first new painkiller approved in the US since Celebrex, a type of nonsteroidal anti-inflammatory drug called a Cox-2 inhibitor, which was approved in 1998.